OncoPep, Inc.
PrivateLast Round
Series D
Dec 9, 2021
Total Funding Raised
$17.9M
Company Overview
OncoPep, Inc. is a biotechnology company that develops targeted peptide-based cancer vaccines and immunotherapeutics for the treatment of multiple myeloma and other cancers.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Precision Medicine, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
OncoPep, Inc. Comparables
Compare OncoPep, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Elicio Therapeutics | 79% | |
| Immatics N.V. | 78% | |
| Sellas Life Sciences Group | 77% |
OncoPep, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series D | Dec 9, 2021 | ||||
| Series B | Aug 28, 2014 | ||||
| VC Round | Apr 26, 2012 |
OncoPep, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Leukemia & Lymphoma Society | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Dec 9, 2021
$11M round led by Kukje Pharma and Tera Science.
- Aug 28, 2014
Raised $7M with Leukemia & Lymphoma Society participating.
OncoPep, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about OncoPep, Inc.'s valuation, stock price, and market status.
Is OncoPep, Inc. a public or private company?
OncoPep, Inc. is a private company.
What is the current stock price of OncoPep, Inc.?
OncoPep, Inc. is a private company with no public stock price. No recent secondary market data is available.
How much is OncoPep, Inc. worth (valuation)?
Valuation information for OncoPep, Inc. is not publicly available.
Can I buy OncoPep, Inc. stock?
OncoPep, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was OncoPep, Inc.'s last funding round?
OncoPep, Inc.'s most recent funding round was Series D on December 9, 2021.
Who are the main investors in OncoPep, Inc.?
Key investors in OncoPep, Inc. include Leukemia & Lymphoma Society.
Will OncoPep, Inc. IPO soon?
No public IPO plans have been announced for OncoPep, Inc..
How can I track OncoPep, Inc. secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor OncoPep, Inc.'s secondary market activity and sign up for updates.